Target intelligence / Profile preview

Duplex DNA (None commonly used)

Target
None commonly used
Molecular classification
Other (Nucleic acid double helix; not a protein, receptor, enzyme, transporter, etc.)
01

Overview

Duplex DNA (double-stranded DNA) refers to the canonical double helix structure formed by two complementary antiparallel strands of deoxyribonucleic acid (DNA), stabilized by hydrogen bonds between purine and pyrimidine bases (A with T, G with C)[2][4][5][8][10]. This fundamental architecture encodes genetic information, serves as the template for replication and transcription, and is essential for heredity and cellular function. The most common form in biological systems is B-form DNA, a right-handed helix with about 10.5 base pairs per turn, but variations such as A-DNA and Z-DNA exist under specific conditions[1][3][5]. While many therapeutic drugs and environmental agents interact with duplex DNA, it is not considered a "therapeutic target" in the traditional sense (i.e., not a protein, enzyme, or classical receptor), but rather a molecular substrate affected by drugs, toxins, and mutagens[5][6]. The term "duplex DNA" is accurate but represents a nucleic acid structure, not a classic drug target; thus, selecting this as a therapeutic target is generally incorrect for structure-activity relationship or drug discovery databases.

Other names
Double-stranded DNADNA double helixdsDNA
02

Mechanism of action

Intercalation between base pairs, disrupting DNA structure and function - Alkylation leading to DNA cross-linking or strand breaks - Inhibition of enzymes (such as topoisomerases or polymerases) interacting with duplex DNA - Chain termination during DNA synthesis (by nucleotide analogs)

03

Biological functions

Storage of genetic informationTemplate for DNA replicationTemplate for transcriptionGenetic inheritance
04

Disease associations

Cancer (when DNA structure or sequence is altered, e.g., mutations)Other (genetic diseases, infectious diseases when targeted by antiviral drugs)
05

Safety considerations

Genotoxicity (agents targeting duplex DNA are often mutagenic and carcinogenic)Cytotoxicity to healthy proliferating cells (e.g., bone marrow, GI tract)Development of drug resistance (in antimicrobials or chemotherapy)Secondary malignancies (due to DNA damage)
06

Interacting drugs

DNA-intercalating agents (e.g., doxorubicin)

4 more in the full profile.

Beyond the preview

Go deeper on Duplex DNA (None commonly used).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Duplex DNA (None commonly used).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call